| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Total revenues [+] | 67.5 | 54.9 | 42.8 | 30.0 | 13.1 | 9.8 | 10.1 | 15.9 |
| Net interest income | | | 4.2 | 0.1 | 0.0 | 0.6 | 0.3 | 0.1 |
| Other income | 1.3 | 1.4 | 0.9 | | | | | |
| Revenue growth | 23.0% | 28.3% | 42.4% | 129.1% | 33.6% | -2.8% | -36.3% | -3.3% |
| Cost of goods sold [+] | 38.4 | 31.3 | 22.5 | 14.8 | 6.3 | 5.6 | 6.2 | 9.1 |
| Labor costs | 36.4 | 28.5 | 20.0 | 13.8 | 5.1 | 4.9 | 5.4 | 8.3 |
| Occupancy costs | 1.9 | 2.8 | 2.6 | 1.0 | 0.4 | 0.7 | 0.8 | 0.8 |
| Gross profit | 29.2 | 23.6 | 20.2 | 15.2 | 6.8 | 4.2 | 3.9 | 6.8 |
| Gross margin | 43.2% | 43.0% | 47.3% | 50.7% | 51.8% | 42.6% | 39.0% | 42.9% |
| Selling, general and administrative [+] | 11.2 | 9.9 | 11.4 | 3.9 | 3.7 | 5.9 | 5.8 | 7.5 |
| Sales and marketing | 0.0 | | 0.0 | 0.0 | 0.1 | 0.3 | 0.3 | 0.2 |
| General and administrative [+] | 11.1 | 9.9 | 11.4 | 3.8 | 3.6 | 5.6 | 5.5 | 7.2 |
| General and administrative expenses | 11.1 | | 11.4 | 3.8 | 3.6 | 5.6 | 5.5 | 7.2 |
| Professional fees | 2.7 | 2.9 | 3.6 | 2.0 | 2.1 | 3.5 | 3.2 | 4.3 |
| Telecommunications expense | | | | | | 0.5 | 0.6 | 0.9 |
| Other selling, general and administrative | | | | | | | | |
| Research and development | | | | 1.0 | 0.4 | | | |
| Equity in earnings | 0.2 | | | | | | | |
| Other operating expenses | 8.9 | 8.6 | 22.4 | 3.1 | 6.5 | 3.9 | 1.2 | 4.1 |
| EBITDA [+] | 9.3 | 5.1 | -13.6 | 7.3 | -3.9 | -5.3 | -2.8 | -4.5 |
| EBITDA growth | 81.2% | -137.7% | -286.0% | -287.5% | -26.6% | 88.8% | -38.1% | -16.0% |
| EBITDA margin | 13.7% | 9.3% | -31.7% | 24.3% | -29.7% | -54.0% | -27.8% | -28.6% |
| Depreciation | 1.3 | 1.4 | 1.0 | 0.1 | 0.1 | 0.3 | 0.3 | 0.3 |
| EBITA | 7.9 | 3.8 | -14.5 | 7.1 | -4.0 | -5.6 | -3.1 | -4.8 |
| EBITA margin | 11.7% | 6.8% | -34.0% | 23.8% | -30.5% | -56.8% | -30.6% | -30.3% |
| Amortization of intangibles | 0.1 | 0.2 | 0.0 | | | | | |
| EBIT [+] | 7.8 | 3.5 | -14.6 | 7.1 | -4.0 | -5.6 | -3.1 | -4.8 |
| EBIT growth | 120.4% | -124.3% | -303.7% | -278.5% | -28.2% | 80.4% | -35.6% | -13.1% |
| EBIT margin | 11.6% | 6.5% | -34.0% | 23.8% | -30.5% | -56.8% | -30.6% | -30.3% |
| Non-recurring items [+] | 0.7 | | | | | | | 1.8 |
| Asset impairment | 0.7 | | | | | | | |
| Loss (gain) on sale of assets | | | | | | | | 1.8 |
| Interest income, net [+] | 3.3 | 3.7 | 4.1 | 0.1 | 0.0 | | | |
| Interest expense | 0.4 | 0.3 | 0.1 | | | | | |
| Interest income | 3.6 | 4.0 | 4.2 | 0.1 | 0.0 | | | |
| Other income (expense), net | -3.6 | -4.0 | 15.8 | 0.1 | 6.3 | 5.6 | -0.1 | 0.0 |
| Pre-tax income | 6.8 | 3.2 | 5.3 | 7.4 | 2.3 | 0.0 | -3.1 | -6.6 |
| Income taxes | 1.7 | 0.2 | 1.0 | -4.6 | 0.2 | 0.0 | -0.3 | 0.0 |
| Tax rate | 25.5% | 6.9% | 19.7% | | 6.6% | | 8.7% | 0.4% |
| Minority interest | 0.0 | | | | | | | |
| Earnings from continuing ops | 5.1 | 3.0 | 4.3 | 12.0 | 2.2 | -5.6 | -2.8 | -6.6 |
| Earnings from discontinued ops | | | | | | | -0.1 | 0.0 |
| Net income | 5.1 | 3.0 | 4.3 | 12.0 | 2.2 | -5.6 | -2.9 | -6.6 |
| Net margin | 7.5% | 5.4% | 10.0% | 39.8% | 16.5% | -56.8% | -28.4% | -41.4% |
| |
| Basic EPS [+] | $0.16 | $0.10 | $0.14 | $0.44 | $0.10 | ($0.25) | ($0.13) | ($0.30) |
| Growth | 66.5% | -31.0% | -68.1% | 359.6% | -137.9% | 98.0% | -57.3% | 12.8% |
| Diluted EPS [+] | $0.16 | $0.10 | $0.14 | $0.44 | $0.10 | ($0.25) | ($0.13) | ($0.30) |
| Growth | 66.5% | -31.0% | -68.1% | 359.6% | -137.9% | 98.0% | -57.3% | 12.8% |
| |
| Dividends per share [+] | | | $0.05 | | | $0.20 | | |
| Growth | | -100.0% | | | -100.0% | | | |
| |
| Shares outstanding (basic) [+] | 31.3 | 30.6 | 30.5 | 27.2 | 22.5 | 22.1 | 22.1 | 22.1 |
| Growth | 2.2% | 0.6% | 12.1% | 20.7% | 1.9% | 0.0% | 0.0% | 0.0% |
| Shares outstanding (diluted) [+] | 31.3 | 30.6 | 30.5 | 27.2 | 22.5 | 22.1 | 22.1 | 22.1 |
| Growth | 2.2% | 0.6% | 12.1% | 20.7% | 1.9% | 0.0% | 0.0% | 0.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |